Building 31, Room 10A24
Bethesda, MD 20892

Speakers and topics for the upcoming consensus conference on breast cancer therapy have been announced as part of the preliminary agenda, which is now available online at http://odp.od.nih.gov/consensus. Registration for the conference at the National Institutes of Health (NIH) in Bethesda, Md., Nov. 1-3, 2000, is also available online.

Like other NIH consensus conferences, the meeting will culminate in recommendations for clinical practice. Conference speakers will consider data on chemotherapy, hormonal therapy, and other aspects of post-surgical (adjuvant) treatment that have emerged in recent years. A panel of experts from outside the NIH will use this information to address seven major questions:

• Which factors should be used to select systemic adjuvant therapy?

• For which patients should adjuvant hormonal therapy be recommended?

• For which patients should adjuvant chemotherapy be recommended? Which agents should be used and at what dose or schedule?

• For which patients should postmastectomy radiotherapy be recommended?

• How do side effects and quality-of-life issues factor into individual decision-making about adjuvant therapy?

• What are promising new research directions?

Those interested in attending the conference can register by going to 
the Web site at http://odp.od.nih.gov/consensus or by sending an e-mail 
to breastcancer@prospectassoc.com. Registration is free. Additional 
information is available by calling (301) 592-3320.

Major sponsors of the Consensus Development Conference on Adjuvant Systemic Therapy for Breast Cancer are the NIH Office of Medical Applications of Research and the National Cancer Institute.

For more information about cancer, visit NCI's Web site at http://www.cancer.gov.